Will Zarxio Battle Continue? Further Launch Delay Could Signal En Banc Review
This article was originally published in The Pink Sheet Daily
Amgen asks Federal Circuit to extend injunction to block Sandoz biosimilar launch until court decides request for en banc review and reaches final decision.
Register for our free email digests: